Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule

Ana RochaUnidade Corino de Andrade, Porto, Portugal, ;Unit for Multidisciplinary Research in Biomedicine (UMIB), Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Porto University, Porto, Portugal, Correspondence[email protected]

Ana SilvaUnidade Corino de Andrade, Porto, Portugal, ;Department of Neurology, Centro Hospitalar do Porto, Porto, Portugal,

Márcio CardosoUnidade Corino de Andrade, Porto, Portugal, ;Department of Neurophisiology, Centro Hospitalar do Porto, Porto, Portugal,

Idalina BeirãoUnidade Corino de Andrade, Porto, Portugal, ;Department of Nephrology, Centro Hospitalar do Porto, Porto, Portugal, and

Cristina AlvesUnidade Corino de Andrade, Porto, Portugal,

Paulo TelesSchool of Economics and LIAAD-INESC Porto LA, Porto University, Porto, Portugal

Teresa CoelhoUnidade Corino de Andrade, Porto, Portugal, ;Department of Neurophisiology, Centro Hospitalar do Porto, Porto, Portugal,

Luísa LobatoUnidade Corino de Andrade, Porto, Portugal, ;Unit for Multidisciplinary Research in Biomedicine (UMIB), Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Porto University, Porto, Portugal, ;Department of Nephrology, Centro Hospitalar do Porto, Porto, Portugal, and

show all

"Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule." Amyloid, 24(sup1), pp. 81–82

Declaration of interest

Dr Coelho has served on the speakers bureau of Pfizer Inc. The other authors report no conflicts of interest.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule

Information for

Open access

Opportunities

Help and information

Transthyretin (ATTR) amyloidosis nephropathy: lessons from a TTR stabilizer molecule

Declaration of interest

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature